VERWENDUNG VON NEUREGULIN-BETA ALS INDIKATOR UND/ODER TARGET

European patent · EP1252186 · Deleted

Register entry

Publication number
EP1252186
Application number
EP01927660
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Feb 9, 2001
Published
Oct 30, 2002
Granted
Jan 11, 2006
Deleted
Feb 29, 2016
Reason
Annual fee unpaid
IPC classes
C07K 14/475 (2006.01)
G01N 33/58 (2006.01)
G01N 33/68 (2006.01)
G01N 33/84 (2006.01)
Priority
DE 10006174 11.02.2000
DE 10006175 11.02.2000
US 248224 P 15.11.2000
PCT application
PCT/EP2001/001424 09.02.2001
PCT publication
WO2001/058948 16.08.2001
Filing language
German
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Sep 21, 2016

    Deleted, fee unpaid

    Published in Swissreg on 21.09.2016

  2. Jul 12, 2014

    Address changed

    Representative
    BOHEST AG, Postfach 160, 4003 Basel → BOHEST AG, Holbeinstrasse 36-38, 4051 Basel

    Published in Swissreg on 12.07.2014

  3. Sep 16, 2011

    Transferred

    Owner
    ProteoSys AG, Carl-Zeiss-Strasse 51, 55129 Mainz, Germany → MIND-NRG SA, 2, rue de Jargonnant, 1207 Geneva

    Published in Swissreg on 16.09.2011

  4. Jun 30, 2008

    Address changed

    Representative
    A. Braun, Braun, Héritier,, Eschmann AG, Patentanwälte, Holbeinstrasse 36-38, 4051 Basel → BOHEST AG, Postfach 160, 4003 Basel

    Published in +pat+ No 12 in 2008

  5. Feb 15, 2006

    Agent entered

    Representative
    A. Braun, Braun, Héritier,, Eschmann AG, Patentanwälte, Holbeinstrasse 36-38, 4051 Basel

    Published in +pat+ No 3 in 2006

  6. Jan 13, 2006

    Granted

    Published in +pat+ No 1 in 2006

Parties

Inventor

SCHRATTENHOLZ, André

55129 Mainz, DE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.